International collaborations preparing for a cancer "moon shot": a summary of the Sino-US Symposium on Head and Neck Cancer.
- Author:
Wei-Wei XIAO
1
,
2
;
Chao-Nan QIAN
Author Information
- MeSH: Carcinoma, Squamous Cell; genetics; Combined Modality Therapy; Drug Delivery Systems; Head and Neck Neoplasms; drug therapy; etiology; genetics; pathology; surgery; Humans; Nasopharyngeal Neoplasms; genetics; pathology; therapy; Thyroid Neoplasms; epidemiology
- From:Chinese Journal of Cancer 2012;31(3):121-125
- CountryChina
- Language:English
- Abstract: Oncologists and scientists in the field of head and neck cancer exchanged their research findings and clinical experiences in the Sino-USA Symposium on Head and Neck Cancer, which was held January 6-7, 2012 in Guangzhou, China. The symposium was jointly organized by Sun Yat-sen University Cancer Center (SYSUCC) and the University of Texas MD Anderson Cancer Center (MDACC). The Guangdong Provincial Anti-Cancer Association and the Chinese Journal of Cancer also helped in organizing the conference. Speakers were from China (SYSUCC, the Chinese University of Hong Kong, Tianjin Medical University Cancer Institute and Hospital, and Fudan University Shanghai Cancer Center) and the United States (MDACC). The presentations covered most kinds of head and neck cancers and included both basic and clinical research progress. In particular, NPC was discussed in depth. The symposium explored the reality that cancer is complex and numerous questions remain to be answered, even though there has already been an enormous effort into research. International exchanges of experience and in-depth cooperation are definitely needed to improve our capability of caring for cancer patients. In this article, we provide highlights of the presentations.
